Cargando…
Diagnostic yield of magnetic resonance imaging for cholangiocarcinoma in primary sclerosing cholangitis: a meta-analysis
AIM OF THE STUDY: Combined magnetic resonance imaging and magnetic resonance cholangiopancreatography (MRI/MRCP) can identify biliary strictures and diagnose primary sclerosing cholangitis (PSC). Diagnosis of cholangiocarcinoma in patients with PSC remains challenging, and the accuracy of MRI/MRCP h...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7062114/ https://www.ncbi.nlm.nih.gov/pubmed/32166122 http://dx.doi.org/10.5114/ceh.2020.93054 |
_version_ | 1783504489762783232 |
---|---|
author | Satiya, Jinendra Mousa, Omar Y Gupta, Kapil Trivedi, Shivani Oman, Sven P Wijarnpreecha, Karn Harnois, Denise M Corral, Juan Enrique |
author_facet | Satiya, Jinendra Mousa, Omar Y Gupta, Kapil Trivedi, Shivani Oman, Sven P Wijarnpreecha, Karn Harnois, Denise M Corral, Juan Enrique |
author_sort | Satiya, Jinendra |
collection | PubMed |
description | AIM OF THE STUDY: Combined magnetic resonance imaging and magnetic resonance cholangiopancreatography (MRI/MRCP) can identify biliary strictures and diagnose primary sclerosing cholangitis (PSC). Diagnosis of cholangiocarcinoma in patients with PSC remains challenging, and the accuracy of MRI/MRCP has not been completely established. We aimed to determine the sensitivity and specificity of MRI/MRCP in the diagnosis of cholangiocarcinoma among patients with PSC from the published literature. MATERIAL AND METHODS: We searched Embase, PubMed, Cochrane, Scopus, ClinicalTrials.gov, and abstracts from relevant scientific meetings and performed a systematic review and meta-analysis to estimate the diagnostic yield of MRI/MRCP in patients with PSC. Sensitivity and specificity were calculated from pooled estimates of cholangiocarcinoma cases identified and lesions missed. Modifying variables were included in a meta-regression model. RESULTS: Our literature search yielded 302 articles and 9 conference abstracts; 8 studies involving 846 liver patients from 5 countries were included in the final analysis. Of those, 531 had PSC and received MRI/MRCP. Thirty-six (6.8%) patients were diagnosed with cholangiocarcinoma (33 true positive, 3 false negative and 1 false positive). Pooled sensitivity was 98.9% (95% CI: 98.6-99.3%). Cholangiocarcinoma cases missed by MRI/MRCP were diagnosed as beading irregularities of the central hepatic ducts, or PSC-related diffuse stricture. Metaregression revealed that neither publication year, study design, nor sample size had a significant effect on observed cancer rates (p = 0.9, 0.3, and 0.3, respectively). CONCLUSIONS: MRI/MRCP followed by endoscopic retrograde cholangiopancreatography (ERCP) is a sensitive and specific tool to diagnose cholangiocarcinoma among patients with PSC. Further research should estimate MRI/MRCP diagnostic accuracy for cholangiocarcinoma using prospective methodology and longer term outcomes. |
format | Online Article Text |
id | pubmed-7062114 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Termedia Publishing House |
record_format | MEDLINE/PubMed |
spelling | pubmed-70621142020-03-12 Diagnostic yield of magnetic resonance imaging for cholangiocarcinoma in primary sclerosing cholangitis: a meta-analysis Satiya, Jinendra Mousa, Omar Y Gupta, Kapil Trivedi, Shivani Oman, Sven P Wijarnpreecha, Karn Harnois, Denise M Corral, Juan Enrique Clin Exp Hepatol Original Paper AIM OF THE STUDY: Combined magnetic resonance imaging and magnetic resonance cholangiopancreatography (MRI/MRCP) can identify biliary strictures and diagnose primary sclerosing cholangitis (PSC). Diagnosis of cholangiocarcinoma in patients with PSC remains challenging, and the accuracy of MRI/MRCP has not been completely established. We aimed to determine the sensitivity and specificity of MRI/MRCP in the diagnosis of cholangiocarcinoma among patients with PSC from the published literature. MATERIAL AND METHODS: We searched Embase, PubMed, Cochrane, Scopus, ClinicalTrials.gov, and abstracts from relevant scientific meetings and performed a systematic review and meta-analysis to estimate the diagnostic yield of MRI/MRCP in patients with PSC. Sensitivity and specificity were calculated from pooled estimates of cholangiocarcinoma cases identified and lesions missed. Modifying variables were included in a meta-regression model. RESULTS: Our literature search yielded 302 articles and 9 conference abstracts; 8 studies involving 846 liver patients from 5 countries were included in the final analysis. Of those, 531 had PSC and received MRI/MRCP. Thirty-six (6.8%) patients were diagnosed with cholangiocarcinoma (33 true positive, 3 false negative and 1 false positive). Pooled sensitivity was 98.9% (95% CI: 98.6-99.3%). Cholangiocarcinoma cases missed by MRI/MRCP were diagnosed as beading irregularities of the central hepatic ducts, or PSC-related diffuse stricture. Metaregression revealed that neither publication year, study design, nor sample size had a significant effect on observed cancer rates (p = 0.9, 0.3, and 0.3, respectively). CONCLUSIONS: MRI/MRCP followed by endoscopic retrograde cholangiopancreatography (ERCP) is a sensitive and specific tool to diagnose cholangiocarcinoma among patients with PSC. Further research should estimate MRI/MRCP diagnostic accuracy for cholangiocarcinoma using prospective methodology and longer term outcomes. Termedia Publishing House 2020-02-17 2020-02 /pmc/articles/PMC7062114/ /pubmed/32166122 http://dx.doi.org/10.5114/ceh.2020.93054 Text en Copyright: © 2020 Clinical and Experimental Hepatology http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license. |
spellingShingle | Original Paper Satiya, Jinendra Mousa, Omar Y Gupta, Kapil Trivedi, Shivani Oman, Sven P Wijarnpreecha, Karn Harnois, Denise M Corral, Juan Enrique Diagnostic yield of magnetic resonance imaging for cholangiocarcinoma in primary sclerosing cholangitis: a meta-analysis |
title | Diagnostic yield of magnetic resonance imaging for cholangiocarcinoma in primary sclerosing cholangitis: a meta-analysis |
title_full | Diagnostic yield of magnetic resonance imaging for cholangiocarcinoma in primary sclerosing cholangitis: a meta-analysis |
title_fullStr | Diagnostic yield of magnetic resonance imaging for cholangiocarcinoma in primary sclerosing cholangitis: a meta-analysis |
title_full_unstemmed | Diagnostic yield of magnetic resonance imaging for cholangiocarcinoma in primary sclerosing cholangitis: a meta-analysis |
title_short | Diagnostic yield of magnetic resonance imaging for cholangiocarcinoma in primary sclerosing cholangitis: a meta-analysis |
title_sort | diagnostic yield of magnetic resonance imaging for cholangiocarcinoma in primary sclerosing cholangitis: a meta-analysis |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7062114/ https://www.ncbi.nlm.nih.gov/pubmed/32166122 http://dx.doi.org/10.5114/ceh.2020.93054 |
work_keys_str_mv | AT satiyajinendra diagnosticyieldofmagneticresonanceimagingforcholangiocarcinomainprimarysclerosingcholangitisametaanalysis AT mousaomary diagnosticyieldofmagneticresonanceimagingforcholangiocarcinomainprimarysclerosingcholangitisametaanalysis AT guptakapil diagnosticyieldofmagneticresonanceimagingforcholangiocarcinomainprimarysclerosingcholangitisametaanalysis AT trivedishivani diagnosticyieldofmagneticresonanceimagingforcholangiocarcinomainprimarysclerosingcholangitisametaanalysis AT omansvenp diagnosticyieldofmagneticresonanceimagingforcholangiocarcinomainprimarysclerosingcholangitisametaanalysis AT wijarnpreechakarn diagnosticyieldofmagneticresonanceimagingforcholangiocarcinomainprimarysclerosingcholangitisametaanalysis AT harnoisdenisem diagnosticyieldofmagneticresonanceimagingforcholangiocarcinomainprimarysclerosingcholangitisametaanalysis AT corraljuanenrique diagnosticyieldofmagneticresonanceimagingforcholangiocarcinomainprimarysclerosingcholangitisametaanalysis |